TickerFacts.

Castle Biosciences Inc (CSTL): Revenue

Annual figures by period end, from SEC filings.

$344.23M
Year ended 2025-12-31
$357.28M
Trailing 12 months to 2026-06-30
+35.9%
3-year compound annual growth
+40.6%
5-year compound annual growth
2018-12-31: $22.79M2019-12-31: $51.87M2020-12-31: $62.65M2021-12-31: $94.08M2022-12-31: $137.04M2023-12-31: $219.79M2024-12-31: $332.07M2025-12-31: $344.23M$344.23M
2018-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$344.23M+3.7%2026-02-26, From 2025-01-01
2024-12-31$332.07M+51.1%2026-02-26, From 2024-01-01
2023-12-31$219.79M+60.4%2026-02-26, From 2023-01-01
2022-12-31$137.04M+45.7%2025-02-27, From 2022-01-01
2021-12-31$94.08M+50.2%2023-02-28, From 2021-01-01
2020-12-31$62.65M+20.8%2022-02-28, From 2020-01-01
2019-12-31$51.87M+127.6%2021-03-11, From 2019-01-01
2018-12-31$22.79Mn/a2020-03-10, From 2018-01-01

Revenue at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Castle Biosciences Inc (CSTL)2025-12-31$344.23M+3.7%
Fulgent Genetics, Inc. (FLGT)2025-12-31$322.67M+13.8%
CareDx, Inc. (CDNA)2025-12-31$379.81M+13.8%
BillionToOne, Inc. (BLLN)2025-12-31$305.11M+100.0%
Veracyte, Inc. (VCYT)2025-12-31$517.14M+16.0%
GRAIL, Inc. (GRAL)2025-12-31$147.17M+17.2%
Caris Life Sciences, Inc. (CAI)2025-12-31$812.03M+97.0%
Guardant Health, Inc. (GH)2025-12-31$982.02M+32.9%
Biodesix Inc (BDSX)2025-12-31$88.50M+24.1%

Compare CSTL, FLGT, CDNA, BLLN side by side · Screen every company in Services-Medical Laboratories ↗